Chemical Component Summary

NameN-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE
IdentifiersN-[(2S,3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-octadecan-2-yl]hexacosanamide
FormulaC50 H99 N O9
Molecular Weight858.322
TypeD-SACCHARIDE
Isomeric SMILESCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)[C@@H]([C@@H](CCCCCCCCCCCCCC)O)O
InChIInChI=1S/C50H99NO9/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-25-26-27-29-31-33-35-37-39-45(54)51-42(41-59-50-49(58)48(57)47(56)44(40-52)60-50)46(55)43(53)38-36-34-32-30-28-16-14-12-10-8-6-4-2/h42-44,46-50,52-53,55-58H,3-41H2,1-2H3,(H,51,54)/t42-,43+,44+,46-,47-,48-,49+,50-/m0/s1
InChIKeyVQFKFAKEUMHBLV-BYSUZVQFSA-N

Chemical Details

Formal Charge0
Atom Count159
Chiral Atom Count8
Bond Count159
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB12232 
NameKRN-7000
Groups investigational
DescriptionKRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT.
Synonyms
  • 1-O-(α-D-galactopyranosyl)-N-hexacosanoylphytosphingosine
  • KRN-7000
Categories
  • Adjuvants, Immunologic
  • Amides
  • Antineoplastic Agents
  • Carbohydrates
  • Ceramides
CAS number158021-47-7

Related Resource References

Resource NameReference
PubChem 2826713
ChEMBL CHEMBL384200
ChEBI CHEBI:466659